 | • レポートコード：QYR9ST02713 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の2型糖尿病市場について調査・分析し、以下の構成でお届け致します。2型糖尿病の種類別には、インスリン、DPP-4阻害剤、GLP-1受容体アゴニスト、SGLT-2阻害剤に、用途別には、ドラッグストア、病院、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別2型糖尿病売上データ ・地域別2型糖尿病市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別2型糖尿病市場規模：インスリン、DPP-4阻害剤、GLP-1受容体アゴニスト、SGLT-2阻害剤 ・用途別2型糖尿病市場規模：ドラッグストア、病院、その他 ・主要メーカーの企業情報：Novo Nordisk、Sanofi、Merck、Eli Lily、AstraZeneca、Astellas Pharma、Daiichi Sankyo、Biocon、Boehringer Ingelheim ・2型糖尿病の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.The dramatic increase in the prevalence, progressive nature and diagnosis of type 2 diabetes is the main driver of this rapid growth rate. The rise in disease-related comorbidities has also fuelled a more aggressive approach to treatment, including the use of multiple-drug therapies.
The Americas dominated the global type 1 diabetes drug market and accounted for close to 50% of the global type 1 diabetes market size. The US was the largest revenue contributor to the diabetes drug market in this region because of the growing prevalence of the disease and rise in obesity. The accessibility to therapies by reimbursement programs is further expected to drive the growth of the diabetes drug market size in the Americas.
The global Type 2 Diabetes market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Type 2 Diabetes market based on company, product type, end user and key regions.
This report studies the global market size of Type 2 Diabetes in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Type 2 Diabetes in these regions.
This research report categorizes the global Type 2 Diabetes market by top players/brands, region, type and end user. This report also studies the global Type 2 Diabetes market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
Market size by Product
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Market size by End User
Drugstore
Hospital
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Type 2 Diabetes market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Type 2 Diabetes market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Type 2 Diabetes companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Type 2 Diabetes submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Type 2 Diabetes are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Type 2 Diabetes market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Type 2 Diabetes Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Type 2 Diabetes Market Size Growth Rate by Product
1.4.2 Insulins
1.4.3 DPP-4 Inhibitors
1.4.4 GLP-1 Receptor Agonists
1.4.5 SGLT-2 Inhibitors
1.5 Market by End User
1.5.1 Global Type 2 Diabetes Market Size Growth Rate by End User
1.5.2 Drugstore
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Type 2 Diabetes Market Size
2.1.1 Global Type 2 Diabetes Revenue 2014-2025
2.1.2 Global Type 2 Diabetes Sales 2014-2025
2.2 Type 2 Diabetes Growth Rate by Regions
2.2.1 Global Type 2 Diabetes Sales by Regions
2.2.2 Global Type 2 Diabetes Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Type 2 Diabetes Sales by Manufacturers
3.1.1 Type 2 Diabetes Sales by Manufacturers
3.1.2 Type 2 Diabetes Sales Market Share by Manufacturers
3.1.3 Global Type 2 Diabetes Market Concentration Ratio (CR5 and HHI)
3.2 Type 2 Diabetes Revenue by Manufacturers
3.2.1 Type 2 Diabetes Revenue by Manufacturers (2014-2019)
3.2.2 Type 2 Diabetes Revenue Share by Manufacturers (2014-2019)
3.3 Type 2 Diabetes Price by Manufacturers
3.4 Type 2 Diabetes Manufacturing Base Distribution, Product Types
3.4.1 Type 2 Diabetes Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Type 2 Diabetes Product Type
3.4.3 Date of International Manufacturers Enter into Type 2 Diabetes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Type 2 Diabetes Sales by Product
4.2 Global Type 2 Diabetes Revenue by Product
4.3 Type 2 Diabetes Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Type 2 Diabetes Breakdown Data by End User
6 North America
6.1 North America Type 2 Diabetes by Countries
6.1.1 North America Type 2 Diabetes Sales by Countries
6.1.2 North America Type 2 Diabetes Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Type 2 Diabetes by Product
6.3 North America Type 2 Diabetes by End User
7 Europe
7.1 Europe Type 2 Diabetes by Countries
7.1.1 Europe Type 2 Diabetes Sales by Countries
7.1.2 Europe Type 2 Diabetes Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Type 2 Diabetes by Product
7.3 Europe Type 2 Diabetes by End User
8 Asia Pacific
8.1 Asia Pacific Type 2 Diabetes by Countries
8.1.1 Asia Pacific Type 2 Diabetes Sales by Countries
8.1.2 Asia Pacific Type 2 Diabetes Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Type 2 Diabetes by Product
8.3 Asia Pacific Type 2 Diabetes by End User
9 Central & South America
9.1 Central & South America Type 2 Diabetes by Countries
9.1.1 Central & South America Type 2 Diabetes Sales by Countries
9.1.2 Central & South America Type 2 Diabetes Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Type 2 Diabetes by Product
9.3 Central & South America Type 2 Diabetes by End User
10 Middle East and Africa
10.1 Middle East and Africa Type 2 Diabetes by Countries
10.1.1 Middle East and Africa Type 2 Diabetes Sales by Countries
10.1.2 Middle East and Africa Type 2 Diabetes Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Type 2 Diabetes by Product
10.3 Middle East and Africa Type 2 Diabetes by End User
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Company Business Overview
11.1.3 Novo Nordisk Type 2 Diabetes Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novo Nordisk Type 2 Diabetes Products Offered
11.1.5 Novo Nordisk Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi Type 2 Diabetes Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi Type 2 Diabetes Products Offered
11.2.5 Sanofi Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Type 2 Diabetes Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Type 2 Diabetes Products Offered
11.3.5 Merck Recent Development
11.4 Eli Lily
11.4.1 Eli Lily Company Details
11.4.2 Company Business Overview
11.4.3 Eli Lily Type 2 Diabetes Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Eli Lily Type 2 Diabetes Products Offered
11.4.5 Eli Lily Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Business Overview
11.5.3 AstraZeneca Type 2 Diabetes Sales, Revenue and Gross Margin (2014-2019)
11.5.4 AstraZeneca Type 2 Diabetes Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Company Business Overview
11.6.3 Astellas Pharma Type 2 Diabetes Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Astellas Pharma Type 2 Diabetes Products Offered
11.6.5 Astellas Pharma Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Details
11.7.2 Company Business Overview
11.7.3 Daiichi Sankyo Type 2 Diabetes Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Daiichi Sankyo Type 2 Diabetes Products Offered
11.7.5 Daiichi Sankyo Recent Development
11.8 Biocon
11.8.1 Biocon Company Details
11.8.2 Company Business Overview
11.8.3 Biocon Type 2 Diabetes Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Biocon Type 2 Diabetes Products Offered
11.8.5 Biocon Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Company Business Overview
11.9.3 Boehringer Ingelheim Type 2 Diabetes Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Boehringer Ingelheim Type 2 Diabetes Products Offered
11.9.5 Boehringer Ingelheim Recent Development
12 Future Forecast
12.1 Type 2 Diabetes Market Forecast by Regions
12.1.1 Global Type 2 Diabetes Sales Forecast by Regions 2019-2025
12.1.2 Global Type 2 Diabetes Revenue Forecast by Regions 2019-2025
12.2 Type 2 Diabetes Market Forecast by Product
12.2.1 Global Type 2 Diabetes Sales Forecast by Product 2019-2025
12.2.2 Global Type 2 Diabetes Revenue Forecast by Product 2019-2025
12.3 Type 2 Diabetes Market Forecast by End User
12.4 North America Type 2 Diabetes Forecast
12.5 Europe Type 2 Diabetes Forecast
12.6 Asia Pacific Type 2 Diabetes Forecast
12.7 Central & South America Type 2 Diabetes Forecast
12.8 Middle East and Africa Type 2 Diabetes Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Type 2 Diabetes Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Type 2 Diabetes Product Picture
Table Type 2 Diabetes Market Segments
Table Key Manufacturers Type 2 Diabetes Covered
Table Global Type 2 Diabetes Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Type 2 Diabetes Sales Market Share by Product 2014-2025
Figure Insulins Product Picture
Table Major Manufacturers of Insulins
Figure DPP-4 Inhibitors Product Picture
Table Major Manufacturers of DPP-4 Inhibitors
Figure GLP-1 Receptor Agonists Product Picture
Table Major Manufacturers of GLP-1 Receptor Agonists
Figure SGLT-2 Inhibitors Product Picture
Table Major Manufacturers of SGLT-2 Inhibitors
Table Global Type 2 Diabetes Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Drugstore
Figure Hospital
Figure Others
Figure Type 2 Diabetes Report Years Considered
Figure Global Type 2 Diabetes Market Size 2014-2025 (Million US$)
Figure Global Type 2 Diabetes Sales 2014-2025 (K MT)
Table Global Type 2 Diabetes Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Type 2 Diabetes Sales by Regions 2014-2019 (K MT)
Table Global Type 2 Diabetes Sales Market Share by Regions 2014-2019
Figure Global Type 2 Diabetes Sales Market Share by Regions 2014-2019
Figure 2018 Global Type 2 Diabetes Sales Market Share by Regions
Table Global Type 2 Diabetes Revenue by Regions 2014-2019 (Million US$)
Table Global Type 2 Diabetes Revenue Market Share by Regions 2014-2019
Figure Global Type 2 Diabetes Revenue Market Share by Regions 2014-2019
Figure 2018 Global Type 2 Diabetes Revenue Market Share by Regions
Table Global Type 2 Diabetes Sales by Manufacturers (2014-2019) (K MT)
Table Global Type 2 Diabetes Sales Share by Manufacturers (2014-2019)
Figure Global Type 2 Diabetes Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Type 2 Diabetes Revenue by Manufacturers (2014-2019) (Million USD)
Table Type 2 Diabetes Revenue Share by Manufacturers (2014-2019)
Figure Type 2 Diabetes Value Share by Manufacturers in 2018
Table Key Manufacturers Type 2 Diabetes Price (2014-2019) (USD/MT)
Table Type 2 Diabetes Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Type 2 Diabetes Product Type
Table Date of International Manufacturers Enter into Type 2 Diabetes Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Type 2 Diabetes Sales by Product (2014-2019) (K MT)
Table Global Type 2 Diabetes Sales Share by Product (2014-2019)
Figure Global Type 2 Diabetes Sales Market Share by Product (2014-2019)
Figure Global Type 2 Diabetes Sales Market Share by Product in 2018
Table Global Type 2 Diabetes Revenue by Product (2014-2019) (Million US$)
Table Global Type 2 Diabetes Revenue Share by Product (2014-2019)
Figure Global Type 2 Diabetes Revenue Market Share by Product (2014-2019)
Figure Global Type 2 Diabetes Revenue Market Share by Product in 2018
Table Type 2 Diabetes Price by Product 2014-2019 (USD/MT)
Table Global Type 2 Diabetes Sales by End User (2014-2019) (K MT)
Table Global Type 2 Diabetes Sales Share by End User (2014-2019)
Figure Global Sales Type 2 Diabetes Market Share by End User (2014-2019)
Figure Global Sales Type 2 Diabetes Market Share by End User in 2018
Figure North America Type 2 Diabetes Sales Growth Rate 2014-2019 (K MT)
Figure North America Type 2 Diabetes Revenue Growth Rate 2014-2019 (Million US$)
Table North America Type 2 Diabetes Sales by Countries (2014-2019) (K MT)
Table North America Type 2 Diabetes Sales Market Share by Countries (2014-2019)
Figure 2018 North America Type 2 Diabetes Sales Market Share by Countries
Table North America Type 2 Diabetes Revenue by Countries (2014-2019) (Million US$)
Table North America Type 2 Diabetes Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Type 2 Diabetes Revenue Market Share by Countries
Figure United States Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure United States Type 2 Diabetes Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Canada Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Table North America Type 2 Diabetes Sales by Product (2014-2019) (K MT)
Table North America Type 2 Diabetes Sales Market Share by Product (2014-2019)
Figure 2018 North America Type 2 Diabetes Market Share by Product
Table North America Type 2 Diabetes Sales by End User (2014-2019) (K MT)
Table North America Type 2 Diabetes Sales Market Share by End User (2014-2019)
Figure 2018 North America Type 2 Diabetes Market Share by End User
Figure Europe Type 2 Diabetes Sales Growth Rate 2014-2019 (K MT)
Figure Europe Type 2 Diabetes Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Type 2 Diabetes Sales by Countries (2014-2019) (K MT)
Table Europe Type 2 Diabetes Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Type 2 Diabetes Sales Market Share by Countries
Table Europe Type 2 Diabetes Revenue by Countries (2014-2019) (Million US$)
Table Europe Type 2 Diabetes Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Type 2 Diabetes Revenue Market Share by Countries
Figure Germany Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Germany Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure France Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure France Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure UK Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Italy Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Russia Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Type 2 Diabetes Sales by Product (2014-2019) (K MT)
Table Europe Type 2 Diabetes Sales Market Share by Product (2014-2019)
Figure 2018 Europe Type 2 Diabetes Market Share by Product
Table Europe Type 2 Diabetes Sales by End User (2014-2019) (K MT)
Table Europe Type 2 Diabetes Sales Market Share by End User (2014-2019)
Figure 2018 Europe Type 2 Diabetes Market Share by End User
Figure Asia Pacific Type 2 Diabetes Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Type 2 Diabetes Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Type 2 Diabetes Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Type 2 Diabetes Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Type 2 Diabetes Sales Market Share by Countries
Table Asia Pacific Type 2 Diabetes Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Type 2 Diabetes Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Type 2 Diabetes Revenue Market Share by Countries
Figure China Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure China Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Japan Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Korea Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure India Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure India Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Australia Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Type 2 Diabetes Sales by Product (2014-2019) (K MT)
Table Asia Pacific Type 2 Diabetes Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Type 2 Diabetes Market Share by Product
Table Asia Pacific Type 2 Diabetes Sales by End User (2014-2019) (K MT)
Table Asia Pacific Type 2 Diabetes Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Type 2 Diabetes Market Share by End User
Figure Central & South America Type 2 Diabetes Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Type 2 Diabetes Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Type 2 Diabetes Sales by Countries (2014-2019) (K MT)
Table Central & South America Type 2 Diabetes Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Type 2 Diabetes Sales Market Share by Countries
Table Central & South America Type 2 Diabetes Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Type 2 Diabetes Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Type 2 Diabetes Revenue Market Share by Countries
Figure Brazil Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Type 2 Diabetes Sales by Product (2014-2019) (K MT)
Table Central & South America Type 2 Diabetes Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Type 2 Diabetes Market Share by Product
Table Central & South America Type 2 Diabetes Sales by End User (2014-2019) (K MT)
Table Central & South America Type 2 Diabetes Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Type 2 Diabetes Market Share by End User
Figure Middle East and Africa Type 2 Diabetes Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Type 2 Diabetes Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Type 2 Diabetes Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Type 2 Diabetes Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Type 2 Diabetes Sales Market Share by Countries
Table Middle East and Africa Type 2 Diabetes Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Type 2 Diabetes Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Type 2 Diabetes Revenue Market Share by Countries
Figure GCC Countries Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Type 2 Diabetes Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Type 2 Diabetes Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Type 2 Diabetes Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Type 2 Diabetes Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Type 2 Diabetes Market Share by Product
Table Middle East and Africa Type 2 Diabetes Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Type 2 Diabetes Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Type 2 Diabetes Market Share by End User
Table Novo Nordisk Company Details
Table Novo Nordisk Type 2 Diabetes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Type 2 Diabetes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Merck Company Details
Table Merck Type 2 Diabetes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Eli Lily Company Details
Table Eli Lily Type 2 Diabetes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Eli Lily Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Type 2 Diabetes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Type 2 Diabetes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Astellas Pharma Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Type 2 Diabetes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Daiichi Sankyo Recent Development
Table Biocon Company Details
Table Biocon Type 2 Diabetes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Biocon Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Type 2 Diabetes Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Global Type 2 Diabetes Sales Forecast by Regions 2019-2025 (K MT)
Table Global Type 2 Diabetes Sales Market Share Forecast by Regions 2019-2025
Table Global Type 2 Diabetes Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Type 2 Diabetes Revenue Market Share Forecast by Regions 2019-2025
Table Global Type 2 Diabetes Sales Forecast by Product 2019-2025 (K MT)
Table Global Type 2 Diabetes Sales Market Share Forecast by Product 2019-2025
Table Global Type 2 Diabetes Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Type 2 Diabetes Revenue Market Share Forecast by Product 2019-2025
Table Global Type 2 Diabetes Sales Forecast by End User 2019-2025 (K MT)
Table Global Type 2 Diabetes Sales Market Share Forecast by End User 2019-2025
Figure North America Type 2 Diabetes Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Type 2 Diabetes Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Type 2 Diabetes Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Type 2 Diabetes Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Type 2 Diabetes Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Type 2 Diabetes Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Type 2 Diabetes Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Type 2 Diabetes Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Type 2 Diabetes Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Type 2 Diabetes Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Type 2 Diabetes Value Chain
Table Type 2 Diabetes Customers List
Table Type 2 Diabetes Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
糖尿病薬物療法の世界市場：インサイト・予測 Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is …- 不適切管理タイプII糖尿病治療の世界市場：市場規模・現状・予測 Diabetes is a serious complex condition which can affect the entire body. Diabetes occurs due to inadequate secretion of insulin inside the pancreas. Insulin secreted by pancreas in hormone made by beta cell which is responsible for the conversion of glucose from food to energy. There are different …
- 糖尿病管理の世界市場：市場規模・現状・予測 Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level.It occurs due to either inefficiency of pancreases to produce insulin (Type I) or unresponsiveness of body cells to the produced insulin (Type II) or both. This condition spe…
- 1型糖尿病の世界市場：市場規模・現状・予測 Type 1 diabetes is a form of diabetes mellitus in which very little or no insulin is produced by the pancreas.The global type 1 diabetes market is expected to grow modestly during the forecast period owing to growing incidence and prevalence of diabetes and cohesive government policies. In 2018, the…
- 非インスリン糖尿病治療薬の世界市場：市場規模・現状・予測 Non-insulin diabetes therapeutics are mostly administered orally and prescribed when diet and exercise are insufficient to control elevated blood glucose levels.In 2018, the global Non-insulin Diabetes Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end …